期刊文献+

HBsAg阳性母亲其婴幼儿联合阻断后无/低应答状态及加强免疫效果 被引量:1

Non-or Low-response Status in Infants of HBsAg Positive Mothers after Hepatitis B Vaccination and How to Strengthen Immune Effects
下载PDF
导出
摘要 目的评价HBsAg阳性母亲其婴幼儿联合阻断后无应答或低应答状态,了解乙肝疫苗加强免疫的干预效果。方法249例HBsAg阳性母亲其婴幼儿出生后予以联合免疫阻断,跟踪并测定出生后7~11个月、12~23个月、24~35个月、≥36个月的HBsAb水平,对其中50例无应答或低应答儿进行乙肝疫苗加强免疫接种,1个月后复查HBsAb水平。结果HBsAg阳性母亲其婴幼儿出生7个月后无应答和低应答的发生率为23.29%(58/249);高应答儿出生12~23个月时无应答和低应答的发生率为37.50%(45/120);持续高应答儿出生24~35个月时无应答和低应答率的发生率为48.14%(13/27)。给予乙肝疫苗加强免疫接种后,幼儿的HBsAb水平增高(P<0.05),加强免疫成功率为94%。性别及加强免疫接种时的年龄不影响加强免疫的效果(P>0.05)。结论HBsAg阳性母亲其婴幼儿全程乙肝疫苗接种后存在无应答及低应答状态,给予乙肝疫苗加强免疫干预后多见高应答状态。 Objective To evaluate the immune response status and changes in infants of HBsAg positive mothers to learn the intervention effects of booster hepatitis B vaccine. Methods Two hundred forty - nine infants of HBsAg positive mothers were given combined immunoblocking after birth. HBsAb levels was detected 7 - 11, 12 - 23, 24 - 35, ~〉 36 months after birth. Fifty non - or low - response cases were given booster hepatitis B vaccine. HBsAb level was re - detected after 1 month. Results The incidence of non - or low - response was 23.29% in infants of HBsAg positive mothers 7 months after birth, 37.43 % in high- response infants 12 -23 months after birth, and 48. 14% in sustained high- response infants 24 -35 months after birth. HBsAb levels increased after booster Hepatitis B vaccine ( P 〈 0. 01 ) , with a success rate of 94%. Gender and age did not affect the effects of booster immunization. Conclusion After intervention of booster hepatitis B vaccine, high response may be noted in infants of HBsAg positive mothers in non - or low - response status after whole range of hepatitis B vaccine.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第3期296-298,共3页 Chinese General Practice
关键词 疾病传播 垂直 肝炎抗体 乙型 加强免疫接种 应答状态 Disease transmission, vertical Hepatitis B antibodies Booster doses Immune response status
  • 相关文献

参考文献9

  • 1Mansoor OD, Salama P. Should hepatitis B vaccine be used for infants? [J]. Expert Rev Vaccines, 2007, 6 (1): 29-33.
  • 2Kabir A, Alavian SM, Ahanchi N, et al. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone [J]. Hepatol Res, 2006, 36 (4): 265 - 271.
  • 3John TJ, Cooksley G. Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations? [ J ]. J Gastroenterol Hepatol, 2005, 20: 5-10.
  • 4Hassan S, Ziba F. Antibody titer in Iranian children 6 years after hepatitis B vaccine administration [J]. Vaccine, 2007, 25 (17) : 3511 -3514.
  • 5Ribeiro TM, Azevedo RS. Seroconversion of hepatitis B vaccine in infants related to the mother's serostatus in a community of Sao Jose dos Campos, state of So Paulo [J]. Brazil Clinics, 2006, 61 (5): 387-394.
  • 6Chen DS. Hepatitis B vaccination : the key towards elimination and eradication of hepatitis B [J]. J Hepatol, 2009, 50 (4): 805-816.
  • 7Bialek SR, Bower WA. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15 -year follow- up study [J]. Pediatr Infect Dis J, 2008, 27 (10): 881-885.
  • 8Sjogren MH. Prevention of hepatitis B in non-responders to initial hepatitis B virus vaccination [J]. Am J Med, 2005, 118 (Suppl 10A) : 34-39.
  • 9Rubin L, Hefer E, Dubnov Y, et al. An evaluation of the efficacy of the national immunization programme for hepatitis [J]. Public Health, 2007, 121 (7): 529-533.

同被引文献22

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部